Long-Term Clinical Outcomes of Korean Patient With Crohn's Disease Following Early Use of Infliximab
Authors:
Open Access
- 1 January 2014
- journal article
- Published by Korean Association for the Study of Intestinal Diseases in Intestinal Research
- Vol. 12 (4) , 281-286
Abstract
Kim NH, et al. Intest Res. 2014 Oct;12(4):281-286. https://doi.org/10.5217/ir.2014.12.4.281Keywords
This publication has 16 references indexed in Scilit:
- Guidelines for the Management of Crohn's DiseaseIntestinal Research, 2012
- Inflammatory Bowel Disease in Korea: Epidemiological, Genomic, Clinical, and Therapeutic CharacteristicsGut and Liver, 2010
- Clinical outcome of newly diagnosed Crohn’s disease: a comparative, retrospective study before and after infliximab availabilityAlimentary Pharmacology & Therapeutics, 2009
- Adalimumab for Maintenance of Clinical Response and Remission in Patients With Crohn’s Disease: The CHARM TrialGastroenterology, 2007
- Infliximab Use in Luminal Crohn's DiseaseGastroenterology Clinics of North America, 2006
- Maintenance infliximab does not result in increased abscess development in fistulizing Crohn's disease: results from the ACCENT II studyAlimentary Pharmacology & Therapeutics, 2006
- Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's diseaseGastrointestinal Endoscopy, 2006
- Maintenance infliximab for Crohn's disease: the ACCENT I randomised trialThe Lancet, 2002
- Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the diseaseGut, 2001
- Infliximab for the Treatment of Fistulas in Patients with Crohn's DiseaseNew England Journal of Medicine, 1999